Total Pancreatectomy for Primary Pancreatic Neoplasms
Authors:
- Alexander GluthAGAlexander Gluth
- Ulf HinzUHUlf Hinz
- Frank BergmannFBFrank Bergmann
- Pauline E. R. SpronkPSPauline E. R. Spronk
- Thilo HackertTHThilo Hackert
- Jens WernerJWJens Werner
- Markus W. BüchlerMBMarkus W. Büchler
- 1 March 2015
- journal article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 261 (3) , 537-546
Abstract
To assess the long-term survival and quality of life in total pancreatectomies and to identify risk factors for perioperative morbidity and mortality. Total pancreatectomy may be required in locally advanced or centrally located pancreatic neoplasms to achieve complete tumor clearance, but available data on short- and long-term results are limited. A total of 434 consecutive total pancreatectomies for primary pancreatic or periampullary tumors were performed between October 2001 and September 2012 at the authors' institution and were prospectively documented and analyzed. Long-term outcome was assessed using Kaplan-Meier and quality of life analysis (EORTC-QLQ-C30 and PAN26). Uni- and multivariate analysis was performed to identify perioperative risk factors and predictors for long-term survival. Extended total pancreatectomies were performed in 54% of cases, with arterial and portal vein resections in 15% and 32%, respectively. Overall 30-day and in-hospital mortality rates were 3.7% and 7.8%, respectively. High blood loss, long operative time, and arterial resections were independently associated with increased perioperative mortality (P ≤ 0.018). In malignant disease, median and 5-year survival were good for standard total pancreatectomies (28.6 months and 24.3%, respectively) and were significantly impaired after vascular resections (P < 0.001). Poor tumor grading, high American Joint Commission on Cancer tumor stage, age more than70 years, and an R1 resection were independent prognostic parameters. Long-term global quality of life was comparable with a matched healthy control group. Standard total pancreatectomy, if needed, is associated with good long-term outcome in pancreatic cancer. Marked surgical morbidity and impaired survival associated with vascular resections reflect the invasiveness of extended total pancreatectomies and the underlying advanced malignant disease.Keywords
This publication has 33 references indexed in Scilit:
- Improvement of surgical results for pancreatic cancerThe Lancet Oncology, 2013
- Early and late postoperative changes in the quality of life after pancreatic surgeryLangenbeck's Archives of Surgery, 2013
- Improving outcome for patients with pancreatic cancer through centralizationBritish Journal of Surgery, 2011
- Trends in Hospital Volume and Operative Mortality for High-Risk SurgeryNew England Journal of Medicine, 2011
- Total pancreatectomy: Indications, different timing, and perioperative and long-term outcomesSurgery, 2011
- Variation in Hospital Mortality Associated with Inpatient SurgeryNew England Journal of Medicine, 2009
- Total Pancreatectomy for Pancreatic AdenocarcinomaAnnals of Surgery, 2009
- Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinomaSurgery, 2007
- Metabolic Consequences of (Regional) Total PancreatectomyAnnals of Surgery, 1991
- Total PancreatectomyAnnals of Surgery, 1970